Key result
Alfentanil blunts hemodynamic changes but not sympathetic responses to rapid desflurane increases.
Why the study?
Fentanyl partially blunts the hemodynamic effects of desflurane but fails to attenuate the sympathetic response, prompting evaluation of alfentanil's effects.
Does alfentanil reduce the neurocirculatory responses to desflurane in healthy male volunteers?
RCT (n=25)
randomized
Does alfentanil reduce the neurocirculatory responses to desflurane in healthy male volunteers?
Alfentanil effectively blunts the hemodynamic changes (tachycardia and hypertension) but not the sympathetic nervous system activation associated with rapid increases in inspired desflurane.
Answers are grounded in this paper and cite their sources.
Alfentanil permits hemodynamic stabilization during desflurane induction; extends evidence of dissociated sympathetic and circulatory responses.
Activation of the sympathetic nervous system occurs in response to desflurane, causing tachycardia and hypertension.Fentanyl partially blunts the hemodynamic effects of desflurane but fails to attenuate the sympathetic response. This study determined the clinical effectiveness and dose response of alfentanil on the neurocirculatory responses to desflurane. Twenty-five healthy, male volunteers were randomized into one of three groups to receive either placebo (n = 9), 10 micro gram/kg intravenous (IV) bolus alfentanil (n = 9), or 20 micro gram/kg IV bolus alfentanil (n = 7) in conjunction with anesthetic induction by propofol, 2.5 mg/kg. Mean arterial pressure (MAP, radial artery), heart rate (HR), and efferent muscle sympathetic nerve activity (SNA, peroneal nerve) were recorded. After conscious baseline measurements, anesthesia was induced by propofol and alfentanil/placebo. One minute later, the desflurane vaporizer was activated at 11%. Neurocirculatory measurements were recorded for 11 min. There were no differences between the groups at conscious baseline. Induction of anesthesia was associated with significantly decreased MAP in the placebo and the 10 micro gram/kg alfentanil groups and increased HR in all groups with little change in SNA. In placebo subjects, desflurane administration increased HR and MAP above baseline. In both alfentanil groups, during desflurane administration HR and MAP never increased significantly above baseline. However, SNA was significantly increased in both groups. Alfentanil effectively blunts the hemodynamic changes but not the sympathetic responses associated with rapid increases in the inspired concentration of desflurane. (Anesth Analg 1996;82:162-6)
No takes yet. Share an insight, caveat, or question.
Yonker-Sell et al. (1996) conducted an RCT in Healthy volunteers undergoing anesthesia (n=25). Alfentanil vs. Placebo was evaluated on Neurocirculatory responses (mean arterial pressure, heart rate, and sympathetic nerve activity). Alfentanil effectively blunted the hemodynamic changes (heart rate and mean arterial pressure) but not the sympathetic responses associated with rapid increases in inspired desflurane.
Synapse has enriched 10 related papers. Consider them for comparative context: